CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,105,191 | -34.5% | 1,625,943 | 0.0% | 13.24% | -1.8% |
| Q2 2023 | $16,942,326 | +49.5% | 1,625,943 | 0.0% | 13.48% | +34.8% |
| Q1 2023 | $11,332,823 | +15.6% | 1,625,943 | 0.0% | 10.01% | +32.5% |
| Q4 2022 | $9,804,436 | -27.4% | 1,625,943 | -4.9% | 7.56% | -29.2% |
| Q3 2022 | $13,500,000 | -42.1% | 1,709,781 | 0.0% | 10.67% | -40.4% |
| Q2 2022 | $23,300,000 | -30.4% | 1,709,781 | 0.0% | 17.91% | -0.6% |
| Q1 2022 | $33,500,000 | -68.9% | 1,709,781 | -45.5% | 18.01% | -44.8% |
| Q4 2021 | $107,600,000 | -37.1% | 3,134,780 | 0.0% | 32.65% | -34.9% |
| Q3 2021 | $171,200,000 | -25.6% | 3,134,780 | 0.0% | 50.12% | +41.8% |
| Q2 2021 | $230,000,000 | -19.8% | 3,134,780 | 0.0% | 35.34% | -24.7% |
| Q1 2021 | $286,707,000 | +12.9% | 3,134,780 | 0.0% | 46.92% | -19.1% |
| Q4 2020 | $254,000,000 | – | 3,134,780 | – | 58.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $107,600,000 | 32.65% |
| Affinity Asset Advisors, LLC | 50,000 | $1,716,000 | 0.62% |
| Renaissance Capital LLC | 21,659 | $743,000 | 0.19% |
| Eversept Partners, LP | 85,017 | $2,916,933 | 0.19% |
| TWINBEECH CAPITAL LP | 67,504 | $2,316,000 | 0.13% |
| Alpine Global Management, LLC | 23,033 | $790,000 | 0.12% |
| Paradigm Financial Advisors, LLC | 13,535 | $464,000 | 0.10% |
| Caption Management, LLC | 200,000 | $6,860,000 | 0.08% |
| Baillie Gifford | 3,923,340 | $134,610,000 | 0.07% |
| Donoghue Forlines LLC | 11,570 | $397,000 | 0.07% |